<DOC>
	<DOCNO>NCT00999050</DOCNO>
	<brief_summary>The aim study evaluate effect Roux-en-y gastric bypass ( RYGB ) control diabetes subject mild obesity ( BMI 26-35 ) . The primary endpoint reduction HbA1c ( &lt; 7 % ) , standard measure diabetes control ; secondary endpoint change blood sugar , vitamin level , insulin , c-peptide , lipids level , well retinal eye examination , urinalysis ass kidney function , carotid ultrasound marker cardiovascular function , alteration diabetic medication . Fifty subject medically document type 2 Diabetes Mellitus ( T2DM ) BMIs 26 35 undergo standard laparoscopic RYGB . Prior surgery , subject undergo clinical evaluation regard primary secondary endpoint list . The pre-surgery evaluation direct toward establish existence diabetes related complication prior surgery . After surgery subject closely monitor complication require change diabetes management . Repeat assessment make 1 , 3 , 6 , 12 month two year .</brief_summary>
	<brief_title>Laparoscopic Gastric Bypass Type 2 Diabetes Mellitus With Body Mass Index ( BMI ) &lt; 35</brief_title>
	<detailed_description>The primary endpoint reduction HbA1c secondary endpoint multiple associate parameter list . A group 50 subject medically document T2DM BMI 26-35 undergo standard laparoscopic RYGB . Prior surgery , subject undergo standard pre-operative work require conventional bariatric surgery . This include full history physical exam , medical/cardiac clearance need , nutrition consultation gastrointestinal consultation upper endoscopy . After thorough explanation approve informed consent sign . Baseline parameter , list , measure subject identify possible complication diabetes prior surgical intervention.. After surgery perioperative complication monitor required modification diabetes management advise . Followed measurements 1 , 3 , 6 , 12 , 24 month consistent standard clinical practice guideline . Data analysis ongoing observe effect surgical intervention glucose homeostasis . - Baseline parameter - History Physical Exam - Weight/BMI/ body composition Tanita 310 . - Waist Circumference - Blood Pressure - CBC - HbA1c - Fasting glucose - Vitamin B6 , B12 , Folate , Iron status - Lipid Profile -total cholesterol , HDL , LDL , triglyceride - Fasting Insulin C-peptide - Stimulated C-peptide - EKG - Retinal exam - Urinalysis ( assess proteinuria microalbuminuria ) - Comprehensive foot exam - Medications dosage - Quality Life Score ( SF-36 ) - Carotid ultrasound ( intima-media thickness ) Follow-up : 4 Weeks : - Physical Examination , wound check , Body weight , BMI , - Glucose Diary ( pre postprandial glucose level require ) - Insulin C-peptide - Lipid profile - Medication use 3 Months , 6 month , Same plus : - HbA1c - Vitamin level iron status - Retinal exam - Annually baseline measurement repeat</detailed_description>
	<mesh_term>Diabetes Mellitus</mesh_term>
	<mesh_term>Diabetes Mellitus , Type 2</mesh_term>
	<criteria>Adult male females meet follow inclusion criterion offer opportunity participate study : 1 . Diagnosis type 2 Diabetes Mellitus ( T2DM ) confirm follow criterion : 1. normal high Cpeptide level ( &gt; 0.9 ng/ml ) exclude type 1 Diabetes Mellitus 2. positive glucagon test confirm T2DM 3. fast plasma glucose 126 mg/dl least two occasion 2 . Body mass index ( BMI ) 26 kg/m2 great , less 35 kg/m2 3 . History T2DM longer 8 year , longstanding disease beyond 8 year correlate failure achieve diabetes resolution gastric bypass 4 . No contraindication surgery general anesthesia determine multidisciplinary bariatric surgery team ( surgeon , anesthesiologist , internist , dietitian , psychologist ) 5 . Between 18 65 year age 6 . Able provide inform consent 7 . If female reproductive potential , agree use reliable method birth control least one year date surgery Exclusion Criteria Subjects meet follow exclusion criterion eligible participate study : 1 . Enrollment another clinical study , involve investigational drug 2 . Diagnosis type 1 Diabetes Mellitus genetic form Diabetes Mellitus 3 . Significant renal failure chronic liver disease ( except NAFLD ) 4 . Major psychological disorder 5 . Pregnancy female subject serum betahCG prior operation , must use birth control choice avoid pregnancy first year surgery 6 . Previous gastric esophageal surgery 7 . Immunosuppressive drug include corticosteroid 8 . Coagulopathy define INR &gt; 1.5 platelet count &lt; 50,000/Âµl 9 . Anemia define Hb &lt; 10.0 g/dl 10 . Inflammatory bowel diseases medical condition would serve contraindication gastric bypass ( eg . celiac sprue , pancreatic insufficiency ) 11 . A severe concurrent illness likely limit life require extensive systemic treatment ( e.g . cancer ) 12 . A preexist major complication diabetes : 1. unstable , proliferative retinopathy 2. severe autonomic cardiac neuropathy intestinal neuropathy 3 . Myocardial infarction within previous year , current unstable angina , poorlycontrolled congestive heart failure ( Stage III )</criteria>
	<gender>All</gender>
	<minimum_age>18 Years</minimum_age>
	<maximum_age>65 Years</maximum_age>
	<verification_date>January 2011</verification_date>
	<keyword>type two diabetes</keyword>
	<keyword>gastric bypass surgery</keyword>
	<keyword>overweight moderately obese</keyword>
</DOC>